Showing 241 - 260 results of 274 for search '"skin cancer"', query time: 0.13s Refine Results
  1. 241

    Bell’s palsy misdiagnosis: characteristics of occult tumors causing facial paralysis by Eun-Jae Chung, Damir Matic, Kevin Fung, S. Danielle MacNeil, Anthony C. Nichols, Ruba Kiwan, KengYeow Tay, John Yoo

    Published 2022-10-01
    “…Four patients were proven to have skin cancers, 3 patients had parotid cancers, and 2 patients had facial nerve schwannomas as a final diagnosis. …”
    Get full text
    Article
  2. 242

    EPIGENETICS TODAY AND TOMORROW by B. F. Vanyushin

    Published 2015-01-01
    “…The inhibitor of DNA methylation 5-azacytidine is used for treatment of skin cancer. Various regulators of enzymatic modifications of histones are efficient in the treatment of different tumors as well. …”
    Get full text
    Article
  3. 243

    The Prevalence of Dermoscopy Use Among Dermatology Residents in Riyadh, Saudi Arabia: Cross-Sectional Study by Abdullah Almeziny, Rahaf Almutairi, Amal Altamimi, Khloud Alshehri, Latifah Almehaideb, Asem Shadid, Mohammed Al Mashali

    Published 2025-01-01
    “…Currently, the vast majority of global guidelines for skin cancer recommend dermoscopy as a critical component. …”
    Get full text
    Article
  4. 244

    A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy by Shang J, Chen Y, Wang F, Yang J, Li Y, Yang L, Liu X, Zhong Z, Yue C, Zhou M

    Published 2025-01-01
    “…Jinlu Shang,1,2,* Yongjun Chen,2,* Fangliang Wang,3,* Jing Yang,2 Yi Li,4 Liuxuan Yang,2 Xiuqiong Liu,1 Zhirong Zhong,5 Chaochi Yue,6 Meiling Zhou2 1Department of Pharmacy, West China Hospital Sichuan University Jintang Hospital, Chengdu, Sichuan, 610400, People’s Republic of China; 2Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 3Chongqing Key Laboratory for Pharmaceutical Metabolism Research, Chongqing Pharmacodynamic Evaluation Engineering Technology Research Center, College of Pharmacy Chongqing Medical University, Chongqing, 400016, People’s Republic of China; 4Department of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 5Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 6Department of Traditional Chinese Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Meiling Zhou; Chaochi Yue, Email meilzhou@163.com; yuechaochi18@swmu.edu.cnBackground: Melanoma is an aggressive form of skin cancer, and single-modality treatments often fail to prevent tumor recurrence and metastasis. …”
    Get full text
    Article
  5. 245
  6. 246
  7. 247
  8. 248
  9. 249

    Clinical implementation of next-generation sequencing testing and genomically-matched therapy: a real-world data in a tertiary hospital by Jin Won Kim, Hee Young Na, Sejoon Lee, Ji-Won Kim, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jaihwan Kim, Jin-Hyeok Hwang, Kihwan Hwang, Chae-Yong Kim, Yong Beom Kim, Soomin Ahn, Kyu Sang Lee, Hyojin Kim, Hye Seung Lee, So Yeon Park, Gheeyoung Choe, Jee Hyun Kim, Jin-Haeng Chung

    Published 2025-01-01
    “…Of patients with tier I variants, 13.7% received NGS-based therapy as follows: Thyroid cancer (2/7, 28.6%), skin cancer (2/8, 25.0%), gynecologic cancer (7/65, 10.8%), and lung cancer (12/112, 10.7%). …”
    Get full text
    Article
  10. 250
  11. 251
  12. 252
  13. 253

    A systematic analysis of the contribution of genetics to multimorbidity and comparisons with primary care dataResearch in context by Olivia Murrin, Ninon Mounier, Bethany Voller, Linus Tata, Carlos Gallego-Moll, Albert Roso-Llorach, Lucía A. Carrasco-Ribelles, Chris Fox, Louise M. Allan, Ruby M. Woodward, Xiaoran Liang, Jose M. Valderas, Sara M. Khalid, Frank Dudbridge, Sally E. Lamb, Mary Mancini, Leon Farmer, Kate Boddy, Jack Bowden, David Melzer, Timothy M. Frayling, Jane A.H. Masoli, Luke C. Pilling, Concepción Violán, João Delgado

    Published 2025-03-01
    “…., iron deficiency anaemia and peripheral arterial disease: genetic correlation Rg = 0.45 [95% Confidence Intervals 0.27:0.64]). 33 pairs displayed negative genetic correlations, such as skin cancer and rheumatoid arthritis (Rg = −0.14 [−0.21:−0.06]), due to potential adverse drug effects. …”
    Get full text
    Article
  14. 254

    Basal Cell Carcinoma of the Female Breast Masquerading as Invasive Primary Breast Carcinoma: An Uncommon Presentation Site by Mark B. Ulanja, Mohamed E. Taha, Arshad A. Al-Mashhadani, Marwah Muaad Al-Tekreeti, Christie Elliot, Santhosh Ambika

    Published 2018-01-01
    “…Skin cancer as a single entity is the most common malignancy in North America, accounting for half of all human cancers. …”
    Get full text
    Article
  15. 255

    Cutaneous Carcinosarcoma with Metastasis to the Parotid Gland by Tze Ling Loh, Jeanne Tomlinson, Ronald Chin, Guy D. Eslick

    Published 2014-01-01
    “…It is similar to nonmelanoma skin cancers in terms of risk and prognostic factors. …”
    Get full text
    Article
  16. 256

    <i>Cordyceps militaris</i>-Derived Bioactive Gels: Therapeutic and Anti-Aging Applications in Dermatology by Trung Quang Nguyen, Thinh Van Pham, Yusuf Andriana, Minh Ngoc Truong

    Published 2025-01-01
    “…In response to the rising incidence of skin cancers and the growing demand for natural bioactive ingredients, <i>C. militaris</i> has emerged as a valuable source of functional compounds, including cordycepin, polysaccharides, and adenosine. …”
    Get full text
    Article
  17. 257

    Erythema Ab Igne due to Heating Pad Use: A Case Report and Review of Clinical Presentation, Prevention, and Complications by Marissa Milchak, Joanne Smucker, Catherine G. Chung, Elizabeth V. Seiverling

    Published 2016-01-01
    “…While this dermatosis carries a favorable prognosis, nonmelanoma skin cancers have been reported to arise within lesions of erythema ab igne. …”
    Get full text
    Article
  18. 258

    Application of adoptive cell therapy in malignant melanoma by Qianrong Hu, Jiangying Xuan, Lu Wang, Kangjie Shen, Zixu Gao, Yuhong Zhou, Chuanyuan Wei, Jianying Gu

    Published 2025-01-01
    “…Abstract Cutaneous melanoma is one of the most aggressive skin cancers originating from skin pigment cells. Patients with advanced melanoma suffer a poor prognosis and generally cannot benefit well from surgical resection and chemo/target therapy due to metastasis and drug resistance. …”
    Get full text
    Article
  19. 259

    RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy by Ichiro Yajima, Mayuko Y. Kumasaka, Nguyen Dinh Thang, Yuji Goto, Kozue Takeda, Osamu Yamanoshita, Machiko Iida, Nobutaka Ohgami, Haruka Tamura, Yoshiyuki Kawamoto, Masashi Kato

    Published 2012-01-01
    “…Cutaneous malignant melanoma is one of the most serious skin cancers and is highly invasive and markedly resistant to conventional therapy. …”
    Get full text
    Article
  20. 260

    Development and Validation of a Simple and Selective Analytical HPLC Method for the Quantification of Oxaliplatin by Breno Noronha Matos, Paula Martins de Oliveira, Thaiene Avila Reis, Taís Gratieri, Marcílio Cunha-Filho, Guilherme Martins Gelfuso

    Published 2015-01-01
    “…Such method will be essential during the future development of innovative, topical drug formulations for the treatment of mucosal and skin cancers. Validated method demonstrated OXPt separation without interference from the solvents or polymers with the most relevance for developing of bioadhesive pharmaceutical drug carries (chitosan and poloxamer). …”
    Get full text
    Article